Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |